My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 113

    1.

    Meta-analysis: vitamin D compounds in chronic kidney disease.

    Palmer SC, McGregor DO, Macaskill P, Craig JC, Elder GJ, Strippoli GF.

    Ann Intern Med. 2007 Dec 18;147(12):840-53.PMID: 18087055 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Outcomes of secondary hyperparathyroidism in chronic kidney disease and the direct costs of treatment.

    Joy MS, Karagiannis PC, Peyerl FW.

    J Manag Care Pharm. 2007 Jun;13(5):397-411. Review.PMID: 17605511 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Effectiveness and safety of vitamin D in relation to bone health.

    Cranney A, Horsley T, O'Donnell S, Weiler H, Puil L, Ooi D, Atkinson S, Ward L, Moher D, Hanley D, Fang M, Yazdi F, Garritty C, Sampson M, Barrowman N, Tsertsvadze A, Mamaladze V.

    Evid Rep Technol Assess (Full Rep). 2007 Aug;(158):1-235. Review.PMID: 18088161 [PubMed - indexed for MEDLINE]Related articles

    4.

    Vitamin D compounds for people with chronic kidney disease requiring dialysis.

    Palmer SC, McGregor DO, Craig JC, Elder G, Macaskill P, Strippoli GF.

    Cochrane Database Syst Rev. 2009 Oct 7;(4):CD005633.PMID: 19821349 [PubMed - in process]Related articles

    5.

    Vitamin D compounds for people with chronic kidney disease not requiring dialysis.

    Palmer SC, McGregor DO, Craig JC, Elder G, Macaskill P, Strippoli GF.

    Cochrane Database Syst Rev. 2009 Oct 7;(4):CD008175.PMID: 19821446 [PubMed - in process]Related articles

    6.

    Interventions for preventing bone disease in kidney transplant recipients.

    Palmer S, McGregor DO, Strippoli GF.

    Cochrane Database Syst Rev. 2005 Apr 18;(2):CD005015. Review. Update in: Cochrane Database Syst Rev. 2007;(3):CD005015. PMID: 15846740 [PubMed - indexed for MEDLINE]Related articles

    7.

    [Changes in mineral metabolism in stage 3, 4, and 5 chronic kidney disease (not on dialysis)]

    Lorenzo Sellares V, Torregrosa V.

    Nefrologia. 2008;28 Suppl 3:67-78. Spanish. PMID: 19018742 [PubMed - indexed for MEDLINE]Related articles

    8.

    Calcimimetics for secondary hyperparathyroidism in chronic kidney disease patients.

    Strippoli GF, Tong A, Palmer SC, Elder G, Craig JC.

    Cochrane Database Syst Rev. 2006 Oct 18;(4):CD006254. Review.PMID: 17054287 [PubMed - indexed for MEDLINE]Related articles

    9.

    Cinacalcet HCl: a novel treatment for secondary hyperparathyroidism caused by chronic kidney disease.

    Torres PU.

    J Ren Nutr. 2006 Jul;16(3):253-8. Review.PMID: 16825031 [PubMed - indexed for MEDLINE]Related articles

    10.

    Challenges in the therapy of secondary hyperparathyroidism.

    Wood C, González EA, Martin KJ.

    Ther Apher Dial. 2005 Feb;9(1):4-8.PMID: 15828898 [PubMed - indexed for MEDLINE]Related articles

    11.

    Beyond minerals and parathyroid hormone: role of active vitamin D in end-stage renal disease.

    Wolf M, Thadhani R.

    Semin Dial. 2005 Jul-Aug;18(4):302-6. Review. Erratum in: Semin Dial. 2007 Jan-Feb;20(1):table of contents. PMID: 16076353 [PubMed - indexed for MEDLINE]Related articles

    12.

    Vitamins for epilepsy.

    Ranganathan LN, Ramaratnam S.

    Cochrane Database Syst Rev. 2005 Apr 18;(2):CD004304. Review.PMID: 15846704 [PubMed - indexed for MEDLINE]Related articles

    13.

    Evidence for persistent vitamin D 1-alpha-hydroxylation in hemodialysis patients: evolution of serum 1,25-dihydroxycholecalciferol after 6 months of 25-hydroxycholecalciferol treatment.

    Jean G, Terrat JC, Vanel T, Hurot JM, Lorriaux C, Mayor B, Chazot C.

    Nephron Clin Pract. 2008;110(1):c58-65. Epub 2008 Aug 25.PMID: 18724068 [PubMed - indexed for MEDLINE]Related articles

    14.

    Extended-interval aminoglycoside administration for children: a meta-analysis.

    Contopoulos-Ioannidis DG, Giotis ND, Baliatsa DV, Ioannidis JP.

    Pediatrics. 2004 Jul;114(1):e111-8.PMID: 15231982 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Vitamin D analogues for the management of secondary hyperparathyroidism.

    Martin KJ, González EA.

    Am J Kidney Dis. 2001 Nov;38(5 Suppl 5):S34-40. Review.PMID: 11689385 [PubMed - indexed for MEDLINE]Related articles

    16.

    Haemoglobin and haematocrit targets for the anaemia of chronic renal disease.

    Strippoli GF, Manno C, Schena FP, Craig JC.

    Cochrane Database Syst Rev. 2003;(1):CD003967. Review. Update in: Cochrane Database Syst Rev. 2006;(4):CD003967. PMID: 12535495 [PubMed - indexed for MEDLINE]Related articles

    17.

    Meta-analysis of biochemical and patient-level effects of calcimimetic therapy.

    Strippoli GF, Palmer S, Tong A, Elder G, Messa P, Craig JC.

    Am J Kidney Dis. 2006 May;47(5):715-26. Review.PMID: 16632010 [PubMed - indexed for MEDLINE]Related articles

    18.

    Drugs for preventing lung cancer in healthy people.

    Caraballoso M, Sacristan M, Serra C, Bonfill X.

    Cochrane Database Syst Rev. 2003;(2):CD002141. Review.PMID: 12804424 [PubMed - indexed for MEDLINE]Related articles

    19.

    The Calcimimetic agent AMG 073 lowers plasma parathyroid hormone levels in hemodialysis patients with secondary hyperparathyroidism.

    Goodman WG, Hladik GA, Turner SA, Blaisdell PW, Goodkin DA, Liu W, Barri YM, Cohen RM, Coburn JW.

    J Am Soc Nephrol. 2002 Apr;13(4):1017-24.PMID: 11912261 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Combined therapy with cinacalcet and low doses of vitamin D sterols in patients with moderate to severe secondary hyperparathyroidism.

    Block GA, Zeig S, Sugihara J, Chertow GM, Chi EM, Turner SA, Bushinsky DA; TARGET Investigators.

    Nephrol Dial Transplant. 2008 Jul;23(7):2311-8. Epub 2008 Feb 29.PMID: 18310602 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity